ASCO 2022

Area: Oncology

Location: Chicago, United States

Date: June 3 to June 7


Search in Scientific Content:
Date
Filters:
Results fr
5:010

Results from the phase 3 PARADIGM trial

Presenter: Yoshino Takayuki
Oncology
Pembrolizu
6:32

Pembrolizumab in CRC: What did we learn from the KEYNOTE-177 and the KEYNOTE-651 trials?

Presenter: Richard D. Kim
Oncology

Bratislava 2014

2014-10-09 - 2014-10-10
Bratislava, Slovakia

ESMO 2014

2014-09-26 - 2014-09-30
Madrid, Spain